购物车
- 全部删除
- 您的购物车当前为空
Motixafortide (BKT140 4-fluorobenzoyl) is an antagonist of CXCR4 (IC50: 1 nM).
Motixafortide (BKT140 4-fluorobenzoyl) is an antagonist of CXCR4 (IC50: 1 nM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥ 3,740 | 5日内发货 |
产品描述 | Motixafortide (BKT140 4-fluorobenzoyl) is an antagonist of CXCR4 (IC50: 1 nM). |
靶点活性 | CXCR4:1 nM |
体外活性 | Motixafortide (BKT140) displays selective toxicity toward AmL and MM cells. Motixafortide (BKT140) specifically triggers CXCR4-dependent cell death in leukemia and MM cells and it stimulates apoptotic cell death in leukemia and MM cells[2]. Treatment with Motixafortide (BKT140) can overcome IL-6 dependent proliferation and survival of ARH77 MM cells. |
体内活性 | Tumors from animals treated with Motixafortide (BKT140) are smaller in size and weights, had larger necrotic areas and high apoptotic scores[2]. Subcutaneous injections of Motixafortide (BKT140) significantly reduces, in a dose-dependent manner, the growth of human acute myeloid leukemia and multiple myeloma xenografts. |
别名 | TF14016, BL-8040, BKT140 (4-fluorobenzoyl) |
分子量 | 2159.52 |
分子式 | C97H144FN33O19S2 |
CAS No. | 664334-36-5 |
密度 | 1.52 g/cm3 (Predicted) |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 36 mg/mL (16.67 mM) | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容